-
"Recombinant human follicle stimulating hormone for injection", Changchun hi tech's first generic drug, is expected to go on the market next year
Time of Update: 2020-04-03
Yang Zhanmin, chairman of Changchun hi tech, said at the 2013 performance presentation meeting that the company is currently promoting the on-site inspection and GMP certification of the first generic
-
Huahai pharmaceutical's production approval of class 3.1 new anti gout drug, non Brest, has been accepted
Time of Update: 2020-04-03
According to the information on June 4 on the website of the State Food and Drug Administration (CFDA), the approval documents for the production of non brescial APIs and tablets for class 3.1 chemica
-
Changshan pharmaceutical heavy weight chemical "daparin sodium injection" review process returned to normal
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on March 31, the review status of the blockbuster drug "heparin sodium" bulk drug and injection in Changshan pharmaceutical in
-
Hengrui paclitaxel and Lizhu eprazole accelerate the review
Time of Update: 2020-04-03
CDE, which has been silent for a long time, has started the habit of issuing announcements every weekend On Friday (October 28), it released the announcement of drug registration application to be inc
-
Xinhua Pharmaceutical class 3.1 constipation treatment drug polycarboxylate non calcium completed the on-site inspection
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on April 2, on-site inspection has been completed for polycarbonate non calcium tablets and APIs, a class 3.1 constipation tre
-
The cell wall skeleton of Nocardia rubra, a new class II biological drug, has been in good operation since it was put into production
Time of Update: 2020-04-03
The cell wall skeleton of Nocardia rubra produced by Liaoning gerst biopharmaceutical Co., Ltd located in the high tech Zone has been in good operation since it was put into production in August It is
-
Moxifloxacin, a new chemical drug of class 3.1 applied for production by new Hecheng, has been accepted
Time of Update: 2020-04-03
According to the public information released by the State Food and Drug Administration on July 29, the new 3.1 chemical drug moxifloxacin declared for production by new Hecheng was accepted This appli
-
HISCO's three chemicals, polyprizine granules, enter the site for inspection
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 23, the three digestive drugs of Hisilicon, polyprizine granules, will enter the site for inspection, which means that
-
Flupentixol-t-melitracen tablets, a new antidepressant drug of hisilic, will be used for the first time in the field
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on April 15, six kinds of new antidepressant drug of Hisilicon, Flupentixol and melitracen tablets, entered the site for inspe
-
Application for registration of "paracetamol oral suspension" of 6 chemical generic drugs of Kangzhi Pharmaceutical Co., Ltd. has been accepted
Time of Update: 2020-04-03
Kangzhi pharmaceutical announced in the afternoon of February 21 that on February 19, 2014, the company received the notice of acceptance of drug registration application from the State Food and Drug
-
Humanwell medicine class 3.1 antiemetic, fosapritam, dimethylmeglumine, has been accepted for clinical application
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 4, Yichang humanwell, a subsidiary of humanwell pharmaceutical Holding Co., Ltd., applied for the clinical application
-
Zhenyuan pharmaceutical is expected to obtain production approval for ademetionine succinate in about one month
Time of Update: 2020-04-03
Adenosylmethionine succinate, a new hepatobiliary drug from Zhenyuan, Zhejiang Province, and its injection status have been changed to "under approval" The company is expected to obtain the production
-
New drugs for chronic hepatitis C in China enter phase III clinical practice
Time of Update: 2020-04-03
"China has the largest number of hepatitis patients in the world, with 93 million hepatitis B carriers, accounting for one third of the global total, while 45 million hepatitis C carriers account for
-
Esomeprazole, a major new drug in Laimei pharmaceutical industry, obtained GMP certificate
Time of Update: 2020-04-03
In the evening of April 1, Laimei pharmaceutical announced that the company received the GMP certificate issued by Chongqing food and drug administration, including esomeprazole API and capsule produc
-
Ibonatide, a new diabetes drug of Changshan pharmaceutical industry, is expected to obtain clinical approval in the second half of the year
Time of Update: 2020-04-03
Changshan pharmaceutical industry said in a conference call that the company's first class 1 new drug, ibuprofen, is expected to obtain the first phase of clinical trial approval and start clinical tr
-
Guizhou bailing develops the ancestral secret recipe of diabetes or 100 million Buyouts
Time of Update: 2020-04-03
Guizhou bailing, which has been acting as the leader of Miao medicine, announced today that the company signed the Miao medicine cooperative development agreement with Yang Guoshun and Yang Ailong on
-
Beijing new pharmaceutical industry: taking off twice by consistency evaluation
Time of Update: 2020-04-03
It is an important task of the 12th Five Year Plan for national drug safety to carry out the evaluation of the consistency of quality and efficacy of generic drugs and comprehensively improve the qua
-
Shanghai Aike Baifa Biomedical Technology Co., Ltd. completed round a financing
Time of Update: 2020-04-03
Shanghai Aike Baifa Biomedical Technology Co., Ltd., a biomedical technology company specializing in the development of new drugs for respiratory virus infection and viral hepatitis, today announced t
-
Yiteng pharmaceutical and Ablynx reached a cooperation agreement on the nanotherapy antibody alx-0141 for osteoporosis
Time of Update: 2020-04-03
On October 14, 2013, Yiteng pharmaceutical, a fast-growing professional pharmaceutical company in China, announced a cooperation with Ablynx pharmaceutical Yiteng pharmaceutical was authorized by Ably
-
Esomeprazole and Utilins of Laimei Pharmaceutical Co., Ltd. have completed the on-site inspection of GMP certification
Time of Update: 2020-04-03
GMP certification is the final review link before the new drugs are put on the market Insiders generally expect that the two new drugs are expected to be put on the market in the first half of this ye
